Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001209191-22-015006

Options or other derivatives

  • SVP Marketing and Corp. Dev. acquired 31,727 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Poirson Allen SVP Marketing and Corp. Dev. 2022-02-28 Grant or award · Stock Option (Right to Buy) +19,081 19,081 D
Poirson Allen SVP Marketing and Corp. Dev. 2022-02-28 Grant or award · Restricted Stock Units +12,646 12,646 D
Loading xslF345X03/doc4.xml…